Delta Investment Management LLC Buys Shares of 4,386 Doximity, Inc. $DOCS

Key Points

• Delta Investment Management LLC has acquired 4,386 shares of Doximity, Inc. (NASDAQ:DOCS), valued at approximately $255,000 during the first quarter.
• Insider trading activity includes notable sales, with Director Regina M. Benjamin selling 10,000 shares for $600,000, indicating a 37.57% decrease in her ownership.
• Doximity's stock recently opened at $68.03, with a reported earnings per share of $0.36, surpassing the consensus estimate and reflecting a 15.2% increase in quarterly revenue year-over-year.

Delta Investment Management LLC bought a new stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 4,386 shares of the company's stock, valued at approximately $255,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of DOCS. VSM Wealth Advisory LLC purchased a new position in Doximity in the first quarter valued at about $29,000. Allworth Financial LP grew its stake in Doximity by 104.0% in the first quarter. Allworth Financial LP now owns 563 shares of the company's stock valued at $32,000 after purchasing an additional 287 shares in the last quarter. National Bank of Canada FI purchased a new position in Doximity in the first quarter valued at about $33,000. Spire Wealth Management grew its stake in Doximity by 73.2% in the first quarter. Spire Wealth Management now owns 615 shares of the company's stock valued at $36,000 after purchasing an additional 260 shares in the last quarter. Finally, Brooklyn Investment Group grew its stake in Doximity by 70.7% in the first quarter. Brooklyn Investment Group now owns 746 shares of the company's stock valued at $43,000 after purchasing an additional 309 shares in the last quarter. Hedge funds and other institutional investors own 87.19% of the company's stock.

Insider Buying and Selling at Doximity

In other news, Director Regina M. Benjamin sold 10,000 shares of the stock in a transaction that occurred on Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total value of $600,000.00. Following the completion of the transaction, the director directly owned 16,618 shares of the company's stock, valued at approximately $997,080. This represents a 37.57% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Kira Scherer Wampler sold 2,000 shares of the stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $57.09, for a total value of $114,180.00. Following the completion of the transaction, the director directly owned 16,618 shares of the company's stock, valued at approximately $948,721.62. The trade was a 10.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 36,000 shares of company stock valued at $2,140,940 in the last quarter. Corporate insiders own 31.30% of the company's stock.

Doximity Stock Up 1.4%

Shares of NASDAQ:DOCS opened at $68.03 on Thursday. The business has a 50 day moving average price of $61.39 and a 200 day moving average price of $60.51. Doximity, Inc. has a twelve month low of $35.32 and a twelve month high of $85.21. The company has a market cap of $12.74 billion, a price-to-earnings ratio of 68.03, a PEG ratio of 4.10 and a beta of 1.36.

Doximity (NASDAQ:DOCS - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same quarter in the prior year, the business posted $0.28 earnings per share. The business's quarterly revenue was up 15.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Analysts anticipate that Doximity, Inc. will post 0.99 EPS for the current year.

Wall Street Analyst Weigh In

DOCS has been the subject of several recent analyst reports. Wells Fargo & Company upped their price target on Doximity from $55.00 to $62.00 and gave the stock an "equal weight" rating in a research note on Monday, August 4th. The Goldman Sachs Group set a $50.00 price target on Doximity and gave the stock a "neutral" rating in a research note on Wednesday, May 21st. William Blair reiterated an "outperform" rating on shares of Doximity in a research note on Friday, May 16th. Piper Sandler upped their price target on Doximity from $65.00 to $69.00 and gave the stock an "overweight" rating in a research note on Monday, August 11th. Finally, Mizuho decreased their price target on Doximity from $65.00 to $60.00 and set a "neutral" rating for the company in a research note on Friday, May 16th. Two research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and eleven have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $66.21.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.